Vitalhub Corp. (TSE:VHI – Free Report) – Analysts at Raymond James decreased their FY2025 earnings estimates for shares of Vitalhub in a report issued on Sunday, May 11th. Raymond James analyst M. Freeman now expects that the company will earn $0.17 per share for the year, down from their previous estimate of $0.23. Raymond James currently has a “Moderate Buy” rating on the stock. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share. Raymond James also issued estimates for Vitalhub’s Q4 2025 earnings at $0.05 EPS, Q2 2026 earnings at $0.07 EPS, Q4 2026 earnings at $0.07 EPS and FY2026 earnings at $0.28 EPS.
A number of other research firms have also recently commented on VHI. Scotiabank set a C$14.00 target price on Vitalhub and gave the stock an “outperform” rating in a research report on Thursday, January 30th. TD Securities raised their price target on Vitalhub from C$13.00 to C$14.00 and gave the stock a “buy” rating in a research note on Monday, March 31st. Finally, Canaccord Genuity Group lifted their price target on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a research report on Thursday, January 16th. Four equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and an average target price of C$12.90.
Vitalhub Price Performance
Shares of VHI opened at C$10.21 on Wednesday. Vitalhub has a 1-year low of C$6.68 and a 1-year high of C$12.34. The stock has a market cap of C$552.28 million, a PE ratio of 166.06, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The firm has a fifty day moving average price of C$10.01 and a 200 day moving average price of C$10.65.
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Articles
- Five stocks we like better than Vitalhub
- The How And Why of Investing in Oil Stocks
- Walmart Stock Alert: Big Price Move Expected Soon
- What is a SEC Filing?
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- About the Markup Calculator
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
